ECOVACS(SH:603486) Zheng Quan Zhi Xing·2025-08-27 09:20Core Viewpoint - The announcement details the results of the 2024 stock option and restricted stock incentive plan of Ecovacs Robotics Co., Ltd., including the number of options and stocks granted, the approval process, and the performance assessment criteria for both company and individual levels [1][4][7]. Group 1: Incentive Plan Overview - The reserved grant registration date for stock options and restricted stocks is August 26, 2025 [1]. - The number of stock options reserved for grant is 3.3824 million, and the number of restricted stocks is 1.5505 million [1][4]. - The number of individuals receiving stock options is 505, while 482 individuals will receive restricted stocks [1][4]. Group 2: Approval Process - The incentive plan has undergone necessary approval procedures, including reviews by the Compensation and Assessment Committee and the Supervisory Board [2][3]. - The Supervisory Board verified the incentive plan and issued relevant opinions on the grant list [2][3]. Group 3: Grant Adjustments - During the funding payment process, two individuals voluntarily waived their stock options, adjusting the total from 507 to 505 individuals and the stock options from 3.3976 million to 3.3824 million [4]. - Similarly, two individuals waived their restricted stocks, adjusting the total from 484 to 482 individuals and the restricted stocks from 1.5581 million to 1.5505 million [8]. Group 4: Performance Assessment Criteria - The performance assessment for the stock options spans three fiscal years (2025-2027), with specific revenue growth targets set for each year: 5% for 2025, 8% for 2026, and 10% for 2027, based on the 2023 revenue [7][12]. - Individual performance assessments will categorize results into five levels, affecting the proportion of options that can be exercised [7][12]. Group 5: Financial Impact - The funds raised from the incentive plan will be used to supplement the company's working capital [16]. - The accounting impact of the granted stock options and restricted stocks will be recorded according to the fair value at the grant date, affecting the company's financial statements over the vesting periods [16].